Startup Alkahest inks a $50M deal for anti-aging R&D FierceBiotech Alkahest, a member of Johnson & Johnson's ($JNJ) just-launched biotech incubator, signed a $50 million agreement with Spanish giant Grifols to hit the gas on its novel approach to treating neurodegeneration. |
No comments:
Post a Comment